Previously overlooked proteins are a potential source for a new class of cancer killing drugs

OICR-affiliated researchers awarded $6.6 million in funding from CIHR

OICR Drug Discovery awarded for COVID-19 research

Innovative drug screening method finds new promising molecules to treat aggressive lung cancers

Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR

Moving in vivo: A case of navigating through translational research roadblocks

Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene

What can we do to better support women in science?

Where are all the women in science?

OICR invests in early-stage Ontario oncology drug development

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research

The Centre for Drug Research and Development (CDRD) and the Ontario Institute for Cancer Research (OICR) team up to advance cutting-edge new cancer treatments